Inactive Instrument

News Alexza Pharmaceuticals, Inc. Nasdaq

Equities

US0153841004

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	16-03-28	PU
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	16-03-15	PU
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	16-03-09	PU
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	16-02-26	PU
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	16-02-24	PU
Alexza Pharmaceuticals : Amends Autoliv Agreement for Heat Packages Used in ADASUVE®	14-12-16	PU
Alexza Pharmaceuticals : Diario Medico Names ADASUVE® in its "Best Ideas of 2014"	14-12-11	PU
Alexza Pharmaceuticals : Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala	14-08-08	PU
Alexza Pharmaceuticals : and Ferrer Announce the Launch of ADASUVE® (inhalation powder, loxapine) in Romania	14-03-13	PU
Alexza Pharmaceuticals, Inc. : Alexza Announces the U.S. Commercial Launch of ADASUVE® by Teva Pharmaceuticals	14-03-03	PU
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference	13-11-21	PU
Alexza Pharmaceuticals, Inc. : Alexza Reports 2013 Third Quarter Financial Results	13-11-06	PU
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals and Grupo Ferrer Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria	13-10-24	PU
Alexza Pharmaceuticals, Inc. : Alexza to Report 2013 Third Quarter Financial Results on Wednesday, November 6, 2013	13-10-16	PU
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013	13-08-29	PU
Alexza Pharmaceuticals, Inc. : Alexza Reports Preliminary 2013 Second Quarter Financial Results	13-08-08	PU
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference	13-08-06	PU
Alexza Pharmaceuticals, Inc. : Alexza Announces Management Promotions	13-08-01	PU
Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals Announces European Launch of ADASUVE® (Staccato® Loxapine)	13-07-30	PU
Alexza Pharmaceuticals, Inc. : Alexza to Report 2013 Second Quarter Financial Results on Thursday, August 8, 2013	13-07-15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alexza Pharmaceuticals, Inc. Nasdaq

Equities

US0153841004

Summary

Filters